KABUL (Pajhwok): The Afghanistan Food and Drug Authority (AFDA) on Sunday clarified that AUDY’s Ceftriaxone injection distilled water issue had been resolved and the medicine was usable.
AFDA on Saturday tweeted: “The laboratory result of Ceftriaxone injection with brand name “AUDY,” a product of Pakistani company Winthro Laboratories Ltd and batch numbers “CV170 and 169 CV” was negative and cannot be used.”
The authority said the laboratory test of Ceftriaxone injection shows its distilled water has insoluble particles and cannot be used.
Pajhwok published this report on Saturday, but Javed Hajir, a spokesman for AFDA, told Pajhwok today: “This . . .
